Viking CEO Brian Lian said at the conference earlier this week that the strategic interest in weight-loss drug deals is ...

Structure CEO warns compounded weight-loss drugs could threaten new obesity treatments as the company prepares to bring its ...

Structure Therapeutics (GPCR) has been in focus after reporting positive phase 2 results for its oral weight loss candidate ...

Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies -- Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of ...

The average one-year price target for Structure Therapeutics Inc. - Depositary Receipt (NasdaqGM:GPCR) has been revised to ...

Structure Therapeutics Inc. (NASDAQ: GPCR) is among the 14 best booming stocks to buy right now. The company’s shares have ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

As of Tuesday, January 13, Structure Therapeutics Inc.’s GPCR share price has surged by 6.29%, which has investors ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Exicure (NASDAQ:XCUR) signed a MOU with GPCR Therapeutics aimed at the acquisition of GPCR USA, a subsidiary of GPCR Therapeutics, and the technology transfer and collaborative research on GPCR ...

Domain Therapeutics becomes Kainova Therapeutics and advances its clinical pipeline of GPCR-modulating therapies: Montreal, Canada Tuesday, January 13, 2026, 18:00 Hrs [IST] Kaino ...